Investigating the relationship between β-blocker and antidepressant use through linkage of the administrative databases of Saskatchewan Health

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 1, 1997, Pages 1-11

  Johnson, Jeffrey A ^a   Wallace, Sylvia M ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

antidepressants; database; linkage; propranolol; Saskatchewan

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; PROPRANOLOL; UNINDEXED DRUG;

ADVERSE DRUG REACTION; ARTICLE; CANADA; DATA BASE; DRUG INFORMATION; DRUG USE; HEALTH CARE; HUMAN; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030933258     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199701)6:1<1::AID-PDS247>3.0.CO;2-7     Document Type: Article

References (21)

1. Avorn, J., Everitt, D. E. and Weiss, S. Increased antidepressant use in patients prescribed beta-blockers. Journal of the American Medical Association 1986; 255: 357-360.
2. Thiessen, B. Q., Wallace, S. M., Blackburn, J. L., Wilson, T. W. and Bergman, U. Increased prescribing of antidepressants subsequent to beta-blocker therapy. Archives of Internal Medicine 1990; 150: 2286-2290.
3. Bright, R. A. and Everitt, D. E. Beta-blockers and depression: Evidence against an association. Journal of the American Medical Association 1992; 267: 1783-1787.
4. Appel, W. C. Letter to the Editor. Journal of the American Medical Association 1986; 255: 3248.
5. Graham, D. J., Lundin, F. E., Fosa, F. and Baum, C. Letter to the Editor. Journal of the American Medical Association 1986; 255: 3249.
6. Mann, S. J. Letter to the Editor. Journal of the American Medical Association 1986; 255: 3248-3249.
7. Scollins, M. J. Letter to the Editor. Journal of the American Medical Association 1986; 255: 3248.
8. Stone, M. Letter to the Editor. Journal of the American Medical Association 1986; 255: 3248.
9. Shapiro, S. The role of automated record linkage in the postmarketing surveillance of drug safety: A critique. Clinical Pharmacology and Therapuetics 1989; 46: 371-386.
10. Tilson, H. H. Getting down to bases: record linkage in Saskatchewan. Canadian Journal of Public Health 1985; 76: 222-223.
11. Strand, L. M. and West, R. Health Data Bases in Saskatchewan. In: Pharmacoepidemiology. Strom, B. L. (Ed.) Churchill Livingstone, New York, 1989, pp. 189-200.
12. Downey, W., Baker, M., Helstone, D., et al. Pharmacoepidemiology in Saskatchewan. Journal of Clinical Research and Pharmacoepidemiology 1990; 4: 117.
13. Malcolm, E., Downey, W., Strand, L. M., McNutt, M. and West, R. Saskatchewan Health's linkable data bases and pharmacoepidemiology. Post Marketing Surveillance 1993; 6: 175-264.
14. Beers, M. H. and Passman, L. J. Antihypertensive medications and depression. Drugs 1990; 40: 792-799.
15. Hennekens, C. E. and Burning, J. E. Epidemiology in Medicine. Little, Brown and Company, Boston, 1987, pp. 287-323.
16. Kleinbaum, D. G., Kupper, L. L. and Morgenstern, H. Epidemiologic Research: Principles and Quantitative Methods. Van Nostrand Reinhold Co Inc., New York, 1982, pp. 320-361.
17. Waal, H. J. Propranolol-induced depression. British Medical Journal 1967; 2: 50.
18. Cremona-Barbaro, A. Propranolol and depression. Lancet 1983; i: 185.
19. Parker, W. A. Propranolol-induced depression and psychosis. Clinical Pharmacy 1985; 4; 214-218.
20. Solomon, G. D. Pharmacology and use of headache medications. Cleveland Journal of Clinical Medicine 1990; 57: 627-635.
21. Taylor, J. W., Cleary, J. D. and Parks, B. R. Primary Headache Disorders. In: Pharmacotherapy: A Pathophysiologic Approach. DiPiro J. T., Talbert, R. L., Hayes, P. E., et al. (Eds) 2nd edn. Elsevier Science Publishing Co., New York; 1992, pp. 942-952.